Let's Talk Medtech with PwC's Glenn Hunzinger

PwC's Glenn Hunzinger stops by to discuss the  https://protect-us.mimecast.com/s/OT4zClYvpnu16jkOlsLCv0B?domain=nam12.safelinks.protection.outlook.com (Pharmaceutical and life sciences deals insights: 2021 midyear outlook report), showcasing the PLS sector returned to normal deal activity with strong deal volume. Plus, Omar Ford, MD+DI's Managing Editor gives his take on the controversial Illumina/Grail merger.